These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2580148)
41. Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation. Wilkes BM J Cardiovasc Pharmacol; 1984; 6(6):1036-42. PubMed ID: 6084759 [TBL] [Abstract][Full Text] [Related]
42. Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Xiang JZ; Linz W; Becker H; Ganten D; Lang RE; Schölkens B; Unger T Eur J Pharmacol; 1985 Jul; 113(2):215-23. PubMed ID: 2995065 [TBL] [Abstract][Full Text] [Related]
44. Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat. Richer C; Doussau MP; Giudicelli JF Am J Cardiol; 1987 Apr; 59(10):12D-17D. PubMed ID: 3034019 [TBL] [Abstract][Full Text] [Related]
46. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876 [TBL] [Abstract][Full Text] [Related]
47. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Otsuka S; Sugano M; Makino N; Sawada S; Hata T; Niho Y Hypertension; 1998 Sep; 32(3):467-72. PubMed ID: 9740612 [TBL] [Abstract][Full Text] [Related]
49. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril. Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542 [TBL] [Abstract][Full Text] [Related]
50. Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats. Becker RH; Baldes L; Treudler M J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S35-9. PubMed ID: 2474099 [TBL] [Abstract][Full Text] [Related]
51. Angiotensin-converting enzyme inhibition, anti-hypertensive activity and hemodynamic profile of trandolapril (RU 44570). Brown NL; Badel MY; Benzoni F; Zanirato J; Vincent JC; Fichelle J; Worcel M Eur J Pharmacol; 1988 Mar; 148(1):79-91. PubMed ID: 3383998 [TBL] [Abstract][Full Text] [Related]
52. Short- and long-term effects of ramipril in hypertension. de Leeuw PW; Birkenhäger WH Am J Cardiol; 1987 Apr; 59(10):79D-82D. PubMed ID: 3034038 [TBL] [Abstract][Full Text] [Related]
53. Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension. Stumpe KO; Overlack A; Kolloch R; Schatz J; Witte PU; Pahnke K Klin Wochenschr; 1986 Jun; 64(12):558-62. PubMed ID: 3016405 [TBL] [Abstract][Full Text] [Related]
54. Angiotensin converting enzyme during acute and chronic enalapril therapy in essential hypertension. Jackson B; Johnston CI Clin Exp Pharmacol Physiol; 1984; 11(4):355-9. PubMed ID: 6097377 [TBL] [Abstract][Full Text] [Related]
55. Role of the kidney in primary hypertension: a renal transplantation study in rats. Rettig R; Folberth C; Stauss H; Kopf D; Waldherr R; Unger T Am J Physiol; 1990 Mar; 258(3 Pt 2):F606-11. PubMed ID: 2138422 [TBL] [Abstract][Full Text] [Related]